H.R. 4121

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

Sponsor: Andy Harris · 0 cosponsors

Follow this bill

Official summary

Written by the Congressional Research Service.

Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026

This bill provides FY2026 appropriations for the Department of Agriculture (USDA), the Food and Drug Administration, and related agencies.

The bill provides appropriations to USDA for agricultural programs, including

  • the Office of the Secretary,
  • Executive Operations,
  • the Economic Research Service,
  • the National Agricultural Statistics Service,
  • the Agricultural Research Service,
  • the National Institute of Food and Agriculture,
  • the Animal and Plant Health Inspection Service,
  • the Agricultural Marketing Service, and
  • the Food Safety and Inspection Service.

The bill also provides appropriations to USDA for farm production and conservation programs, including

  • the Farm Production and Conservation Business Center,
  • the Farm Service Agency,
  • the Risk Management Agency, and
  • the Natural Resources Conservation Service.

The bill provides appropriations to the Federal Crop Insurance Corporation Fund and the Commodity Credit Corporation Fund.

For USDA rural development programs, the bill includes appropriations for

  • Salaries and Expenses,
  • the Rural Housing Service,
  • the Rural Business-Cooperative Service, and
  • the Rural Utilities Service.

The bill provides appropriations to the Food and Nutrition Service for

  • Child Nutrition Programs;
  • the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC);
  • the Supplemental Nutrition Assistance Program (SNAP);
  • the Commodity Assistance Program; and
  • Nutrition Programs Administration.

The bill provides appropriations to the Foreign Agricultural Service for (1) Food for Peace Title II Grants, and (2) McGovern-Dole International Food for Education and Child Nutrition Program Grants.

The bill also provides appropriations for

  • the Food and Drug Administration,
  • the Commodity Futures Trading Commission, and
  • the Farm Credit Administration.

Additionally, the bill sets forth requirements and restrictions for using funds provided by this and other appropriations acts.

Text of the bill

Expand all

I AGRICULTURAL PROGRAMS

II

III RURAL DEVELOPMENT PROGRAMS

IV

V FOREIGN ASSISTANCE AND RELATED PROGRAMS

VI

VII GENERAL PROVISIONS

Sec. 733.

Out of the funds provided by this Act to the Food and Drug Administration (in this section referred to as the ‘‘FDA’’), or provided from any accounts in the Treasury derived by the collection of fees available to the agencies funded by this Act, not less than $200,000,000 shall be used by the Commissioner of Food and Drugs for enforcement activities related to e-cigarettes, vapes, and other electronic nicotine delivery systems (in this section referred to as ‘‘ENDS’’), including—

(1) updating the FDA document titled ‘‘Enforcement Priorities for Electronic Nicotine Delivery System (ENDS) and Other Deemed Products on the Market Without Premarket Authorization’’, published in January 2020 and updated on April 13, 2020—

(A) to expand FDA’s prioritized enforcement to flavored disposable ENDS products in addition to cartridge-based products; and

(B) to define the term ‘‘disposable ENDS product’’;

(2) preparing and making publicly available on the FDA website a list of products, to be updated monthly, that have—

(A) received marketing granted orders pursuant to section 910(c)(1)(A)(i) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 4 387j(c)(1)(A)(i));

(B) received marketing denial orders pursuant to section 910(c) of such Act (21 U.S.C. 7 387j(c)) that have been and remain stayed by the Secretary or through court order, rescinded by the Secretary, or vacated by a court; or

(C) submitted a premarket tobacco product application pursuant to section 910(b) of such Act (21 U.S.C. 387j(b)), which remains pending review since on or before September 9, 2020;

(3) continuing the activities of the Federal multi-agency task force led by the Department of Justice and the FDA to further work to bring all available criminal and civil tools to bear against the illegal manufacture, importation, distribution, and sale of e-cigarettes, vapes, and other ENDS products from the Republic of China and other foreign countries; and

(4) submitting a semi-annual written report to the Committees on Appropriations of both Houses of Congress on the progress that the Center for Tobacco Products is making in removing all illegal ENDS products from the market.